% Expired Patents = 50.0

Trademarks = 1

Forward Citations = 14

Loading Chart...

7 inventors (with patents filed for the assignee):

Nozer M Mehta (4 out of 37 patents)

James P Gilligan (3 out of 24 patents)

William Stern (2 out of 30 patents)

4. Jesmond P Dalli (1 out of 5 patents)

5. Mauro Perretti (1 out of 6 patents)

6. Amy M Sturmer (1 out of 11 patents)

7. Angelo P Consalvo (1 out of 21 patents)

4 patents: Sort by Forward Citations

1. 9220758 - Calcitonin products and therapies for treating inflammatory or degenerative diseases (2015-12-29),

2. 9102753 - Anti-inflammatory pharmaceutical products (2015-08-11),

3. 8835377 - Oral delivery of peptide pharmaceutical compositions (2014-09-16),

4. 8497347 - Methods of treating medical conditions using peptides (2013-07-30),

Company Overview

UGP Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of various diseases. With a focus on precision medicine and targeted drug delivery, UGP Therapeutics is committed to improving patient outcomes and quality of life. Through cutting-edge research and collaborations with leading scientists, UGP Therapeutics aims to bring novel treatments to market that address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#666 in Chicago, IL

#2,841 in Illinois

#60,671 in US

Chicago, IL, United States of America

Ugp Therapeutics, Inc.

Forward Citations = 14

7 inventors:

Nozer M Mehta (4 out of 37 patents)

James P Gilligan (3 out of 24 patents)

William Stern (2 out of 30 patents)

4. Jesmond P Dalli (1 out of 5 patents)

5. Mauro Perretti (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ugp Therapeutics, Inc.. Retrieved from https://idiyas.com/company/ugp-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]